Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Azilsartan Medoxomil in the Treatment of Patients With Essential Hypertension and Type 2 Diabetes in Asia

NCT02517866 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT02517866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02517866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Azilsartan Medoxomil in the Treatment of Patients With Essential Hypertension and Type 2 Diabetes in Asia
Lead sponsor
Takeda
Phase
Phase 4
Overall status
Completed
Start date
July 13, 2015
Completion date
November 25, 2016
Enrollment
380 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension, type 2 diabetes mellitus